These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 1651691

  • 1. Calcium antagonists increase the amount of mRNA for the low-density lipoprotein receptor in skin fibroblasts.
    Eckardt H, Filipovic I.
    Artery; 1991; 18(4):168-83. PubMed ID: 1651691
    [Abstract] [Full Text] [Related]

  • 2. LDL receptor gene expression in human mesangial cells under the influence of calcium channel blockers.
    Ruan XZ, Varghese Z, Fernando R, Powas SH, Moorhead JF.
    Clin Nephrol; 1999 May; 51(5):263-71. PubMed ID: 10363626
    [Abstract] [Full Text] [Related]

  • 3. [Calcium channel blockers inhibit human low-density lipoprotein peroxidation induced by oxygen free radicals in vitro].
    Napoli C, Ambrosio G, Palumbo G, Chiariello P, Chiariello M.
    Cardiologia; 1992 Nov; 37(11):801-4. PubMed ID: 1298553
    [Abstract] [Full Text] [Related]

  • 4. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W, Müller-Wieland D, Nägele H, Behnke B, Greten H.
    J Cardiovasc Pharmacol; 1987 Nov; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [Abstract] [Full Text] [Related]

  • 5. Calmodulin antagonists increase the amount of mRNA for the low-density-lipoprotein receptor in skin fibroblasts.
    Eckardt H, Filipovic I, Hasilik A, Buddecke E.
    Biochem J; 1988 Jun 15; 252(3):889-92. PubMed ID: 3421929
    [Abstract] [Full Text] [Related]

  • 6. Calcium channel blockers stimulate LDL receptor synthesis in human skin fibroblasts.
    Filipovic I, Buddecke E.
    Biochem Biophys Res Commun; 1986 May 14; 136(3):845-50. PubMed ID: 3718500
    [Abstract] [Full Text] [Related]

  • 7. Regulation of low-density lipoprotein metabolism by cell density and proliferative state.
    Kenagy R, Bierman EL, Schwartz S.
    J Cell Physiol; 1983 Sep 14; 116(3):404-8. PubMed ID: 6309872
    [Abstract] [Full Text] [Related]

  • 8. Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation.
    Chait A, Bierman EL, Albers JJ.
    J Clin Invest; 1979 Nov 14; 64(5):1309-19. PubMed ID: 227931
    [Abstract] [Full Text] [Related]

  • 9. The 1996 Lindberg Award. Calcium antagonists alter cell shape and induce procollagenase synthesis in keloid and normal human dermal fibroblasts.
    Doong H, Dissanayake S, Gowrishankar TR, LaBarbera MC, Lee RC.
    J Burn Care Rehabil; 1996 Nov 14; 17(6 Pt 1):497-514. PubMed ID: 8951536
    [Abstract] [Full Text] [Related]

  • 10. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N, Devaraj SN, Devaraj H.
    Eur J Nutr; 2003 Oct 14; 42(5):262-71. PubMed ID: 14569407
    [Abstract] [Full Text] [Related]

  • 11. Effects of nifedipine, verapamil and diltiazem on serum biochemical parameters and aortic composition of atherosclerotic chickens.
    García-Pérez B, Ayala I, Castells MT, Doménech G, Sánchez-Polo MT, García-Partida P, Valdés M.
    Biomed Pharmacother; 2005 Oct 14; 59(1-2):1-7. PubMed ID: 15740928
    [Abstract] [Full Text] [Related]

  • 12. [Enhancement on expression of LDL receptors in cultured rhesus renal epithelial cells by verapamil].
    Liu NF.
    Zhongguo Yao Li Xue Bao; 1994 Mar 14; 15(2):183-6. PubMed ID: 8010118
    [Abstract] [Full Text] [Related]

  • 13. Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2.
    Corsini A, Granata A, Fumagalli R, Paoletti R.
    Pharmacol Res Commun; 1986 Jan 14; 18(1):1-16. PubMed ID: 3006091
    [Abstract] [Full Text] [Related]

  • 14. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A, Salvayre R.
    Br J Pharmacol; 1992 Nov 14; 107(3):738-44. PubMed ID: 1472971
    [Abstract] [Full Text] [Related]

  • 15. Role of microtubules in low density lipoprotein processing by cultured cells.
    Ostlund RE, Pfleger B, Schonfeld G.
    J Clin Invest; 1979 Jan 14; 63(1):75-84. PubMed ID: 216709
    [Abstract] [Full Text] [Related]

  • 16. Bunazosin enhances receptor-mediated endocytosis of low-density lipoproteins.
    Matsunaga A, Hidaka K, Sasaki J, Arakawa K.
    Artery; 1992 Jan 14; 19(6):307-17. PubMed ID: 1361724
    [Abstract] [Full Text] [Related]

  • 17. Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture.
    Stein O, Leitersdorf E, Stein Y.
    Arteriosclerosis; 1985 Jan 14; 5(1):35-44. PubMed ID: 3966907
    [Abstract] [Full Text] [Related]

  • 18. Comparative effect of ursodeoxycholic acid and calcium antagonists on the binding, uptake and degradation of LDL in isolated hamster hepatocytes.
    Bouscarel B, Ceryak S, Fromm H.
    Biochim Biophys Acta; 1996 Jun 11; 1301(3):230-6. PubMed ID: 8664333
    [Abstract] [Full Text] [Related]

  • 19. Calcium antagonists and low density lipoprotein receptors.
    Paoletti R, Bernini F, Fumagalli R, Allorio M, Corsini A.
    Ann N Y Acad Sci; 1988 Jun 11; 522():390-8. PubMed ID: 3377372
    [Abstract] [Full Text] [Related]

  • 20. Effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic blocking activity, on the low-density lipoprotein receptor in human skin fibroblasts.
    Matsunaga A, Inoue T, Koga T, Mori K, Kugi M, Sasaki J, Arakawa K.
    Cardiovasc Drugs Ther; 1997 Dec 11; 11(6):747-50. PubMed ID: 9512869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.